Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Operating Expenses: 2018-2023

Historic Operating Expenses for Therapeutics (RAPT) over the last 6 years, with Dec 2023 value amounting to $127.1 million.

  • Therapeutics' Operating Expenses rose 35.96% to $33.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $127.1 million, marking a year-over-year increase of 45.51%. This contributed to the annual value of $127.1 million for FY2023, which is 45.51% up from last year.
  • Latest data reveals that Therapeutics reported Operating Expenses of $127.1 million as of FY2023, which was up 45.51% from $87.3 million recorded in FY2022.
  • Therapeutics' Operating Expenses' 5-year high stood at $127.1 million during FY2023, with a 5-year trough of $43.6 million in FY2019.
  • For the 3-year period, Therapeutics' Operating Expenses averaged around $95.8 million, with its median value being $87.3 million (2022).
  • Data for Therapeutics' Operating Expenses shows a peak YoY skyrocketed of 45.51% (in 2023) over the last 5 years.
  • Therapeutics' Operating Expenses (Yearly) stood at $43.6 million in 2019, then surged by 33.53% to $58.3 million in 2020, then climbed by 25.35% to $73.0 million in 2021, then increased by 19.58% to $87.3 million in 2022, then soared by 45.51% to $127.1 million in 2023.